Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -92,427 | -42,850 | 40,772 | -41,634 | -10,136 |
| Depreciation Amortization | 4,543 | 2,211 | 7,156 | 5,244 | 3,375 |
| Accounts receivable | -3,553 | -177 | -5,899 | -6,056 | -4,596 |
| Accounts payable and accrued liabilities | -6,001 | 156 | -610 | -5,114 | -2,890 |
| Other Working Capital | -13,046 | -11,368 | -39,083 | -33,430 | -51,339 |
| Other Operating Activity | 32,956 | 7,923 | 221,489 | 96,081 | 115,409 |
| Operating Cash Flow | $-77,528 | $-44,105 | $223,825 | $15,091 | $49,823 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -96,692 | -101,110 | 10,024 | 43,549 | 21,437 |
| PPE Investments | -558 | -209 | -1,596 | -1,418 | -1,389 |
| Investing Cash Flow | $-97,250 | $-101,319 | $8,428 | $42,131 | $20,048 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,649 | 1,945 | 11,574 | 9,185 | 7,409 |
| Other Financing Activity | -76 | -76 | -23,507 | -23,507 | -13,492 |
| Financing Cash Flow | $3,573 | $1,869 | $-11,933 | $-14,322 | $-6,083 |
| Exchange Rate Effect | 83 | 9 | 92 | -25 | -8 |
| Beginning Cash Position | 309,250 | 309,250 | 88,838 | 88,838 | 88,838 |
| End Cash Position | 138,128 | 165,704 | 309,250 | 131,713 | 152,618 |
| Net Cash Flow | $-171,122 | $-143,546 | $220,412 | $42,875 | $63,780 |
| Free Cash Flow | |||||
| Operating Cash Flow | -77,528 | -44,105 | 223,825 | 15,091 | 49,823 |
| Capital Expenditure | -558 | -209 | -1,596 | -1,418 | -1,389 |
| Free Cash Flow | -78,086 | -44,314 | 222,229 | 13,673 | 48,434 |